No Data
Analysts Are Bullish on These Healthcare Stocks: Elutia (ELUT), Monopar Therapeutics Inc (MNPR)
Leerink Partners Sticks to Its Buy Rating for Monopar Therapeutics Inc (MNPR)
Cantor Fitzgerald Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $109
Analysts' Top Healthcare Picks: Monopar Therapeutics Inc (MNPR), First Tracks Biotherapeutics Inc (TRAX)
A Quick Look at Today's Ratings for Monopar Therapeutics(MNPR.US), With a Forecast Between $104 to $130
Wall Street Analysts Are Bullish on Top Healthcare Picks